4.7 Article

Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 211, Issue 6, Pages 1079-1091

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20131131

Keywords

-

Funding

  1. European Research Council [311335]
  2. Swedish Research Council
  3. Swedish Foundation for Strategic Research
  4. Swedish Cancer Foundation
  5. Swedish Children's Cancer Foundation
  6. Histiocytosis Association
  7. Jeansson's Foundation
  8. Ake Wiberg's Foundation
  9. Karolinska Institute Research Foundation
  10. Frontiers in Biomedical Research Fellowship
  11. University of Minnesota T32 Haematology Training Grant
  12. Frederick National Laboratory for Cancer Research
  13. National Institutes of Health [HHSN261200800001E]
  14. Intramural Research Program of National Institutes of Health, Frederick National Laboratory, Center for Cancer Research
  15. European Research Council (ERC) [311335] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Autosomal recessive mutations in UNC13D, the gene that encodes Munc13-4, are associated with familial hemophagocytic lymphohistiocytosis type 3 (FHL3). Munc13-4 expression is obligatory for exocytosis of lytic granules, facilitating cytotoxicity by T cells and natural killer (NK) cells. The mechanisms regulating Munc13-4 expression are unknown. Here, we report that Munc13-4 is highly expressed in differentiated human NK cells and effector CD8(+) T lymphocytes. A UNC13D c. 118-308C> T mutation, causative of FHL3, disrupted binding of the ETS family member ELF1 to a conserved intronic sequence. This mutation impairs UNC13D intron 1 recruitment of STAT4 and the chromatin remodeling complex component BRG1, diminishing active histone modifications at the locus. The intronic sequence acted as an overall enhancer of Munc13-4 expression in cytotoxic lymphocytes in addition to representing an alternative promoter encoding a novel Munc13-4 isoform. Mechanistically, T cell receptor engagement facilitated STAT4-dependent Munc13-4 expression in naive CD8+ T lymphocytes. Collectively, our data demonstrates how chromatin remodeling within an evolutionarily conserved regulatory element in intron 1 of UNC13D regulates the induction of Munc13-4 expression in cytotoxic lymphocytes and suggests that an alternative Munc13-4 isoform is required for lymphocyte cytotoxicity. Thus, mutations associated with primary immunodeficiencies may cause disease by disrupting transcription factor binding.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

Jeffrey S. Miller, Zachary B. Davis, Erika Helgeson, Cavan Reilly, Ann Thorkelson, Jodi Anderson, Noemia S. Lima, Siri Jorstad, Geoffrey T. Hart, John H. Lee, Jeffrey T. Safrit, Hing Wong, Sarah Cooley, Lavina Gharu, Hyunsoo Chung, Patrick Soon-Shiong, Curtis Dobrowolski, Courtney Fletcher, Jonathan Karn, Daniel C. Douek, Timothy W. Schacker

Summary: N-803 is a safe and potential treatment for reducing virus reservoirs in people living with HIV by activating latent virus and enhancing immune cell function.

NATURE MEDICINE (2022)

Letter Oncology

Childhood Kaposi sarcoma related to hypomorphic severe combined immunodeficiency caused by a novel CORO1A mutation

Audrone Muleviciene, Takuya Sekine, Timo Zondag, Yenan T. Bryceson, Bianca Tesi, Jelena Rascon

PEDIATRIC BLOOD & CANCER (2022)

Review Immunology

Neuroinflammation Associated With Inborn Errors of Immunity

Hannes Lindahl, Yenan T. Bryceson

Summary: The development of high-throughput sequencing has advanced the understanding of genotype-phenotype correlations in congenital diseases. Neuroinflammatory diseases, although rare, are increasingly recognized among inborn errors of immunity and can have a significant impact on patient care. This review focuses on the signs and symptoms of neuroinflammation associated with pathogenic variants in immune genes and proposes a subdivision based on underlying mechanisms.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Human cytomegalovirus alters immune cell profile with potential implications for patient survival in head and neck cancer

Heather H. Nelson, Emma Contestabile, De Von Hunter-Schlichting, Devin Koestler, Michael Pawlita, Tim Waterboer, Brock C. Christensen, Curtis L. Petersen, Jeffrey S. Miller, Karl T. Kelsey

Summary: Cytomegalovirus (CMV) infection alters T cell proportions, but does not increase the risk of HPV16 infection or head and neck cancer. Our findings, based on serology and tumor biomarkers, suggest that CMV is associated with worse patient survival.

CARCINOGENESIS (2022)

Letter Biochemistry & Molecular Biology

Studying severe long COVID to understand post-infectious disorders beyond COVID-19

Petter Brodin, Giorgio Casari, Liam Townsend, Cliona O'Farrelly, Ivan Tancevski, Judith Loeffler-Ragg, Trine H. Mogensen, Jean Laurent Casanova

NATURE MEDICINE (2022)

Review Immunology

Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID-19 in chronic lymphocytic leukaemia?

Carl Inge Edvard Smith, Rula Zain, Anders osterborg, Marzia Palma, Marcus Buggert, Peter Bergman, Yenan Bryceson

Summary: The scarcity of plasmacytoid dendritic cells (pDCs) in patients with chronic lymphocytic leukaemia (CLL) may contribute to the severe clinical course of COVID-19 in these patients. Treatment of CLL with Bruton's tyrosine kinase (BTK) inhibitors can increase the number of pDCs.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2022)

Article Immunology

Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency

Tessa Mollie Campbell, Zhiyong Liu, Qian Zhang, Marcela Moncada-Velez, Laura E. Covill, Peng Zhang, Ilad Alavi Darazam, Paul Bastard, Lucy Bizien, Giorgia Bucciol, Sara Lind Enoksson, Emmanuelle Jouanguy, Semsi Nur Karabela, Taushif Khan, Yasemin Kendir-Demirkol, Andres Augusto Arias, Davood Mansouri, Per Marits, Nico Marr, Isabelle Migeotte, Leen Moens, Tayfun Ozcelik, Isabelle Pellier, Anton Sendel, Sevtap Senoglu, Mohammad Shahrooei, C. I. Edvard Smith, Isabelle Vandernoot, Karen Willekens, Kadriye Kart Yasar, Peter Bergman, Laurent Abel, Aurelie Cobat, Jean-Laurent Casanova, Isabelle Meyts, Yenan T. Bryceson

Summary: IRF7-deficient individuals are prone to viral infections of the respiratory tract but are otherwise healthy, potentially due to residual IFN-beta and compensatory adaptive immunity.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Immunology

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

Qian Zhang, Daniela Matuozzo, Jeremie Le Pen, Danyel Lee, Leen Moens, Takaki Asano, Jonathan Bohlen, Zhiyong Liu, Marcela Moncada-Velez, Yasemin Kendir-Demirkol, Huie Jing, Lucy Bizien, Astrid Marchal, Hassan Abolhassani, Selket Delafontaine, Giorgia Bucciol, Gulsum Ical Bayhan, Sevgi Keles, Ayca Kiykim, Selda Hancerli, Filomeen Haerynck, Benoit Florkin, Nevin Hatipoglu, Tayfun Ozcelik, Guillaume Morelle, Mayana Zatz, Lisa F. P. Ng, David Chien Lye, Barnaby Edward Young, Yee-Sin Leo, Clifton L. Dalgard, Richard P. Lifton, Laurent Renia, Isabelle Meyts, Emmanuelle Jouanguy, Lennart Hammarstrom, Qiang Pan-Hammarstrom, Bertrand Boisson, Paul Bastard, Helen C. Su, Stephanie Boisson-Dupuis, Laurent Abel, Charles M. Rice, Shen-Ying Zhang, Aurelie Cobat, Jean-Laurent Casanova

Summary: In an international cohort of 112 hospitalized children with COVID-19 pneumonia, 12 children with recessive inborn errors of type I interferon immunity were identified. These deficiencies may contribute to the development of COVID-19 pneumonia in children. Additionally, these deficiencies were not found in individuals without pneumonia from SARS-CoV-2 infection.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Multidisciplinary Sciences

Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner

Victoria Walker-Sperling, Jean C. Digitale, Mathias Viard, Maureen P. Martin, Arman Bashirova, Yuko Yuki, Veron Ramsuran, Smita Kulkarni, Vivek Naranbhai, Hongchuan Li, Stephen K. Anderson, Lauren Yum, Robert Clifford, Hannah Kibuuka, Julie Ake, Rasmi Thomas, Sarah Rowland-Jones, John Rek, Emmanuel Arinaitwe, Moses Kamya, Isabel Rodriguez-Barraquer, Margaret E. Feeney, Mary Carrington

Summary: Two single-nucleotide polymorphisms regulating TAPBP mRNA expression were identified in Africans, associated with lower Plasmodium falciparum parasite prevalence and lower incidence of clinical malaria among individuals carrying tapasin-dependent HLA-I allotypes.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Medicine, Research & Experimental

Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion

Jacob A. Myers, Dawn Schirm, Laura Bendzick, Rachel Hopps, Carly Selleck, Peter Hinderlie, Martin Felices, Jeffrey S. Miller

Summary: This paper investigates the mechanisms and reversal strategies of NK cell exhaustion, and proposes an in vitro model as a valuable tool for studying exhaustion regulation processes.

JCI INSIGHT (2022)

Article Oncology

Reverse Translation Identifies the Synergistic Role of Immune Checkpoint Blockade and IL15 to Enhance Immunotherapy of Ovarian Cancer

Martin Felices, Erin Wesley, Laura E. Bendzick, Behiye Kodal, Rachel Hopps, Bartosz Grzywacz, Peter Hinderlie, Jeffrey S. Miller, Melissa A. Geller

Summary: We investigated the effects of combined treatment with an IL15 superagonist (N-803) and immune checkpoint blockade (ICB) on immune activation in ovarian cancer patients. Our results showed that N-803 stimulated initial expansion of natural killer (NK) cells in patients, and combining ICB enhanced NK cell function. In preclinical studies, the combination of N-803 and ICB also showed improved anti-tumor control and enhanced NK cell persistence and expansion in vivo.

CANCER IMMUNOLOGY RESEARCH (2023)

Review Oncology

Advances in NK cell therapy for brain tumors

Jawad Fares, Zachary B. Davis, Julian S. Rechberger, Stephanie A. Toll, Jonathan D. Schwartz, David J. Daniels, Jeffrey S. Miller, Soumen Khatua

Summary: Despite current treatment advancements for brain tumors, including surgery, chemotherapy, and radiation, the prognosis remains poor, especially for recurrent cases. The close proximity to delicate neural structures often prevents complete surgical removal, and the toxicities of systemic therapy are a concern. However, the field of NK cell-based cancer therapy shows promise as a new avenue for treating brain tumors.

NPJ PRECISION ONCOLOGY (2023)

Article Hematology

Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease

Shernan G. Holtan, Andrea Hoeschen, Qing Cao, Celalettin Ustun, Brian C. Betts, Najla El Jurdi, Joseph Maakaron, Armin Rashidi, Jeffrey S. Miller, John E. Wagner, Bruce R. Blazar, Pamala A. Jacobson, Angela Panoskaltsis-Mortari, Daniel J. Weisdorf, Margaret L. Macmillan

Summary: Studies have shown that treatments that aid inflammation resolution, immune tolerance, and epithelial repair may improve outcomes for life-threatening acute graft-versus-host disease (aGVHD) beyond traditional immunosuppressants. Addition of urinary-derived human chorionic gonadotropin/epidermal growth factor (uhCG/EGF) to standard aGVHD therapy has been found to be a feasible supportive care measure with potential to reduce morbidity and mortality. Further research is needed to explore the efficacy of uhCG/EGF as a complementary treatment for aGVHD.

TRANSPLANTATION AND CELLULAR THERAPY (2023)

Article Hematology

CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell Transplantation

Armin Rashidi, Corinna La Rosa, Julie Curtsinger, Qing Cao, Qiao Zhou, Chetan Raj Lingaraju, Daniel J. Weisdorf, Frank Cichocki, Jeffrey S. Miller, Don J. Diamond

Summary: This study evaluated whether vaccination with a recombinant modified vaccinia Ankara expressing CMV antigens could improve the reconstitution of adaptive NK cells and CMV-specific T cells after auto-HCT in lymphoma and myeloma patients. The results showed that the vaccine increased the abundance of adaptive NK cells and CMV-specific T cells, suggesting a potential role in preventing relapse.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

Article Hematology

High Proliferating Regulatory T Cells Post-Transplantation Are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation

Nuttavut Sumransub, Qing Cao, Rose Wangen, Claudio Brunstein, Jeffrey S. Miller, Veronika Bachanova

Summary: This study analyzed the patterns of regulatory T cell reconstitution after autologous hematopoietic cell transplantation in non-Hodgkin lymphoma patients and found that the level of proliferating Tregs at day +28 post-transplantation was associated with patient survival.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

No Data Available